Microsurgical repair after crush-avulsion injury of the femoral vein in rats: Prevention of microvascular thrombosis with recombinant human tissue-type plasminogen activator (rt-PA)

Microsurgery

Volumn 21, Issue 8, 2001, Pages 357-361

  Lykoudis, Efstathios G ^a,b   Contodimos, George B ^a   Tsoutsos, Dimosthenis A ^a   Frangia, Konstantina B ^a   Papalois, Apostolos E ^a   Stamatopoulos, Constantinos N ^a   Ioannovich, John D ^a  

^a IASO GENERAL HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVULSION INJURY; BLOOD FLOW; CONTROLLED STUDY; CRUSH TRAUMA; FEMORAL VEIN; GRAFT PATENCY; MALE; MICROSURGERY; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SURGERY; VEIN THROMBOSIS;

ANIMALS; FEMORAL VEIN; MALE; MICROSURGERY; PLASMINOGEN ACTIVATORS; RATS; RATS, WISTAR; TISSUE PLASMINOGEN ACTIVATOR; VASCULAR PATENCY; VENOUS THROMBOSIS;

EID: 0035674198     PISSN: 07381085     EISSN: None     Source Type: Journal    
DOI: 10.1002/micr.21808     Document Type: Article

References (24)

1. Results after replantation in the upper extremity in children
2. Fingertip replantations: Clinical evaluation of 135 digits
3. Microvascular free flaps the first decade
4. Use of anticoagulants in replantation and elective microsurgery
5. Tissue-type plasminogen activator a review of its pharmacology and therapeutic use as a thrombolytic agent
6. A comparison of human recombinant tissue-type plasminogen activator and urokinase in microsurgical thrombolysis in the rat
7. Antithrombotic effects of thrombolytic agents in a platelet-rich femoral vein thrombosis model in the hamster
8. Microvascular repair following a modified crushavulsion injury in a rat model: Effect of recombinant human tissuetype plasminogen activator on the patency rate
9. Microvascular repair following local crush and avulsion injury
10. Thrombosis of microvascular anastomoses in traumatized vessels: Fibrin versus platelets
11. Photochemically induced thrombosis model in rat femoral artery and evaluation of effects of heparin and tissue-type plasminogen activator with use of this model
12. Prevention of microvascular thrombosis by topical application of recombinant tissue factor pathway inhibitor
13. Use of thrombolytic drugs in non-coronary disorders
14. Effects of streptokinase and urokinase on microarterial thrombosis and haemostasis
15. One-year results from the Global utilization of streptokinase and TPA for occluded coronary arteries (GUSTO-I) trial
16. Life-threatening pulmonary embolism with right-sided heart thrombus. Rapid recovery with recombinant tissue plasminogen activator
17. Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis
18. Lysis block treatment: A new form of local thrombolysis
19. Prevention of microvascular thrombosis with low dose tissue plasminogen activator
20. Prevention of microvascular thrombosis with short-term infusion of human tissue-type plasminogen activator
21. Microvascular repair with -mm polytetrafluoroethylene (PTFE) grafts: Effect of recombinant tissue-type plasminogen activator (rt-PA) on the patency rate and healing process
22. Intraoperative thrombolytic treatment of microarterial occlusion by selective rt-PA infusion
23. Local intravenous thrombolysis with recombinant tissue plasminogen activator for salvage of forearm replantation
24. Local recombinant tissue plasminogen activator (rt-PA) thrombolytic therapy in microvascular surgery